PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives.

Degennaro P, Ghafir El Idrissi I, Purgatorio R, Fanizzi A, Rullo M, Pisani L, Macchia E, Torsi L, Stefanachi A, Leonetti F

Open source

DOI
10.3390/ph19091352
Published
2026 Aug 26
Container
Pharmaceuticals (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/ph19091352,
  title = {PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives.},
  author = {Degennaro P and Ghafir El Idrissi I and Purgatorio R and Fanizzi A and Rullo M and Pisani L and Macchia E and Torsi L and Stefanachi A and Leonetti F},
  year = {2026},
  journal = {Pharmaceuticals (Basel, Switzerland)},
  doi = {10.3390/ph19091352},
  url = {https://doi.org/10.3390/ph19091352}
}

RIS

TY  - JOUR
TI  - PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives.
AU  - Degennaro P
AU  - Ghafir El Idrissi I
AU  - Purgatorio R
AU  - Fanizzi A
AU  - Rullo M
AU  - Pisani L
AU  - Macchia E
AU  - Torsi L
AU  - Stefanachi A
AU  - Leonetti F
PY  - 2026
JO  - Pharmaceuticals (Basel, Switzerland)
DO  - 10.3390/ph19091352
UR  - https://doi.org/10.3390/ph19091352
ER  - 

APA

P, D., I, G. E. I., R, P., A, F., M, R., L, P., E, M., L, T., A, S., & F, L. (2026). PROTAC-Based Strategies in Neurodegenerative Diseases: Challenges and Perspectives.. Pharmaceuticals (Basel, Switzerland). https://doi.org/10.3390/ph19091352

Source records